𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Dynamics of DNA repair suggested by the subcellular localization of Brca1 and Brca2 proteins

✍ Scribed by L. Julie Huber; Lewis A. Chodosh

Publisher
John Wiley and Sons
Year
2005
Tongue
English
Weight
254 KB
Volume
96
Category
Article
ISSN
0730-2312

No coin nor oath required. For personal study only.

✦ Synopsis

Abstract

The localization of proteins to specific subcellular compartments often reveals clues regarding their biological functions. Although significant progress has been made towards understanding how damaged DNA is repaired, experiments to date have primarily focused on signal transduction pathways that activate DNA repair protein complexes and on how these complexes are assembled. Current evidence suggests that certain DNA repair processes are spatially organized such that aberrant DNA structures can be brought into proximity with DNA repair proteins at fixed sites. Since biochemical evidence suggests that the tumor suppressor proteins, Brca1 and Brca2, may mediate the assembly of protein complexes involved in the repair of damaged DNA, we have performed subcellular fractionation experiments to determine the subnuclear localization of these proteins. The majority of Brca1 and Brca2 proteins were found to interact tightly with the nuclear matrix. Furthermore, within the limits of detection, localization of Brca1 and Brca2 to the nuclear matrix was not altered following treatment of cells with DNA damaging agents that activate homology‐mediated double‐stranded DNA break and transcription‐coupled repair pathways. Our findings suggest that Brca1 and Brca2 may perform their DNA repair‐related functions from positions that are anchored to the nuclear matrix. These data are consistent with proposed models that suggest that components of specific repair complexes residing on the nuclear matrix function to recruit damaged DNA. © 2005 Wiley‐Liss, Inc.

📜 SIMILAR VOLUMES

On the dynamics of breast tumor developm
On the dynamics of breast tumor development in women carrying germline BRCA1 and BRCA2 mutations
✍ Richard Simon; Xinan Zhang 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 French ⚖ 65 KB

## Abstract We used mathematical models to analyze the age‐incidence curve of breast carcinoma for individuals carrying a germline mutation in the BRCA1 or BRCA2 gene locus. Although many genomic abnormalities have been identified in breast tumors, we found that a two‐stage model fit the data well.

Germ-line mutations in BRCA1 or BRCA2 in
Germ-line mutations in BRCA1 or BRCA2 in the normal breast are associated with altered expression of estrogen-responsive proteins and the predominance of progesterone receptor A
✍ Patricia A. Mote; Jennifer A. Leary; Kelly A. Avery; Kerstin Sandelin; Georgia C 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 177 KB 👁 1 views

## Abstract The breast cancer susceptibility genes __BRCA1__ and __BRCA2__ are responsible for a large proportion of familial breast and ovarian cancer, yet little is known of how disruptions in the functions of the proteins these genes encode increased cancer risk preferentially in hormone‐depende

Does the nonsense-mediated mRNA decay me
Does the nonsense-mediated mRNA decay mechanism prevent the synthesis of truncated BRCA1, CHK2, and p53 proteins?
✍ Olga Anczuków; Mark D. Ware; Monique Buisson; Almoutassem B. Zetoune; Dominique 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 373 KB

The nonsense-mediated mRNA decay (NMD) mechanism is an evolutionarily conserved process ensuring the degradation of transcripts carrying premature termination codon(s). NMD is believed to prevent the synthesis of truncated proteins that could be detrimental to the cell. However, although numerous st

Alteration of G1 cell-cycle protein expr
Alteration of G1 cell-cycle protein expression and induction of p53 but not p21/waf1 by the DNA-modifying carcinogen 2-acetylaminofluorene in growth-stimulated hepatocytes in vitro
✍ Birgitte Lindeman; Ellen Skarpen; G. Hege Thoresen; Thoralf Christoffersen; Lene 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 282 KB 👁 1 views

2-Acetylaminofluorene (AAF) is a potent tumor promoter in rat liver carcinogenesis models. In the resistant hepatocyte model, AAF is combined with a growth stimulus for efficient promotion of preneoplastic lesions. The promoting property of AAF in this model is closely associated with mito-inhibitio